Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer

Clinical Cancer Research

Volumn 12, Issue 7 I, 2006, Pages 2066-2069

  Ohuchida, Kenoki ^a   Mizumoto, Kazuhiro ^a   Yamada, Daisuke ^a   Yamaguchi, Hiroshi ^a   Konomi, Hiroyuki ^a   Nagai, Eishi ^a   Yamaguchi, Koji ^a   Tsuneyoshi, Masazumi ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LYMPHOCYTE; MAJOR CLINICAL STUDY; MICRODISSECTION; PANCREAS CANCER; PANCREAS JUICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; RNA, MESSENGER; TELOMERASE;

EID: 33646254159     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1821     Document Type: Article

References (28)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
2. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995;76:1671-7.
3. Nakaizumi A, Tatsuta M, Uehara H, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique. Cancer 1992;70:2610-4.
4. Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E. Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis. In Vivo 1992;6:297-301.
5. Mitchell ML, Carney CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol 1985;83:171-6.
6. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
7. Tsukuda H, Matsumura Y, Inoue T, et al. Diagnostic application of CD44 variant expression in pancreatic juice for detection of pancreatic neoplasm. Anticancer Res 2001;21:2175-83.
8. Ohhashi K, Murakami Y, Takekoshi T, et al. Four cases of "mucin-producing" cancer of the pancreas on specific findings of the papilla of Vater. Progress Digest Endoscopy 1982;20:348-51.
9. Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484-90.
10. Suehara N, Mizumoto K, Muta T, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 1997;3:993-8.
11. Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997;57:326-31.
12. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997;3:2479-83.
13. Uehara H, Nakaizumi A, Tatsuta M, et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol 1999;94:2513-8.
14. Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation. Gastrointest Endosc 2000;51:708-13.
15. Gertler R, Rosenberg R, Stricker D, et al. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 2002;95:2103-11.
16. Lehner R, Enomoto T, McGregor JA, et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 2002;84:120-5.
17. Bieche I, Nogues C, Paradis V, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:452-9.
18. Seki K, Suda T, Aoyagi Y, et al. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin Cancer Res 2001;7:1976-81.
19. Ohuchida K, Mizumoto K, Ogura Y, et al. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005;11:2285-92.
20. Black WC, Welch HG. Screening for disease. AJR Am J Roentgenol 1997;168:3-11.
21. Ohuchida K, Mizumoto K, Ishikawa N, et al. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors. Cancer 2004;101:2309-17.
22. Tachikawa T, Irie T. A new molecular biology approach in morphology: basic method and application of laser microdissection. Med Electron Microsc 2004;37:82-8.
23. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
24. Ikeda S, Matsumoto S, Yoshimoto H, Tanaka M, Yamaguchi K. Endoscopic balloon catheter pancreatography using catheter retaining technique [in Japanese with an English abstract). Stomach Intestine 1984;19:1231-42.
25. Takagi S, Kinouchi Y, Chida M, et al. Strong telomerase activity of B lymphocyte from mesenteric lymph nodes of patients with inflammatory bowel disease. Dig Dis Sci 2003;48:2091-4.
26. Hathcock KS, Jeffrey Chiang Y, Hodes RJ. In vivo regulation of telomerase activity and telomere length. Immunol Rev 2005;205:104-13.
27. Yamanishi Y, Hiyama K, Ishioka S, et al. Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases. Int J Mol Med 1999;4:513-7.
28. Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer 2001;91:35-41.